Which adverse reactions were most frequently reported with Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Gilead in treatment-naïve adults in clinical studies through 144 weeks?

Nausea (16%) and diarrhoea (12%) were the most frequently reported adverse reactions considered possibly or probably related to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Gilead in treatment-naïve adults in clinical studies through 144 weeks.